Scinai Immunotherapeutics Ltd. (SCNI)

Scinai Immunotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2	2	6	34	32	93
Market Cap Growth	-60.86%	-60.86%	-83.58%	5.57%	-65.86%	199.75%
Enterprise Value	6	18	13	45	48	110
PE Ratio	-	-0.33	-0.95	-4.10	-25.37	-3.03
PB Ratio	-0.47	-0.47	-3.14	34.30	-7.74	-5.09
P/FCF Ratio	-0.22	-0.22	-0.68	-4.45	-1.44	-3.92
P/OCF Ratio	-0.23	-0.23	-0.76	-4.54	-1.56	-4.30
EV/EBITDA Ratio	-2.96	-2.96	-2.46	-5.84	12.55	-5.08
EV/EBIT Ratio	-2.73	-2.73	-2.22	-5.50	15.28	-4.98
EV/FCF Ratio	-1.77	-1.77	-1.59	-5.97	-2.18	-4.61
Debt / Equity Ratio	-4.50	-4.50	-12.24	29.52	-4.60	-2.02
Debt / EBITDA Ratio	-3.43	-3.43	-4.12	-3.75	4.93	-1.71
Debt / FCF Ratio	-2.05	-2.05	-2.66	-3.83	-0.86	-1.55
Quick Ratio	2.81	2.81	6.08	7.17	0.17	3.86
Current Ratio	3.06	3.06	6.15	7.30	0.17	3.86
Interest Coverage	-	-	-	-	0.72	-2.54
Return on Equity (ROE)	135.50%	135.50%	-345.70%	-291.80%	12.80%	231.60%
Return on Assets (ROA)	-32.80%	-32.80%	-23.40%	-30.80%	-5.80%	-106.50%
Return on Capital (ROIC)	-60.69%	-60.69%	-55.91%	-36.25%	13.95%	-118.30%
Earnings Yield	-375.33%	-300.34%	-104.83%	-24.36%	-3.94%	-32.98%
FCF Yield	-153.37%	-462.94%	-146.52%	-22.46%	-69.46%	-25.52%
Buyback Yield / Dilution	-107.22%	-107.22%	-33.57%	-27.37%	-35.70%	-24.95%
Total Shareholder Return	-107.22%	-107.22%	-33.57%	-27.37%	-35.70%	-24.95%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).